Cite
Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068.
MLA
Zhou, Nannan, et al. “Genotypic Correlates of Susceptibility to HIV-1 Attachment Inhibitor BMS-626529, the Active Agent of the Prodrug BMS-663068.” Journal of Antimicrobial Chemotherapy (JAC), vol. 69, no. 3, Mar. 2014, pp. 573–81. EBSCOhost, https://doi.org/10.1093/jac/dkt412.
APA
Zhou, N., Nowicka-Sans, B., McAuliffe, B., Ray, N., Eggers, B., Fang, H., Fan, L., Healy, M., Langley, D. R., Hwang, C., Lataillade, M., Hanna, G. J., & Krystal, M. (2014). Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068. Journal of Antimicrobial Chemotherapy (JAC), 69(3), 573–581. https://doi.org/10.1093/jac/dkt412
Chicago
Zhou, Nannan, Beata Nowicka-Sans, Brian McAuliffe, Neelanjana Ray, Betsy Eggers, Hua Fang, Li Fan, et al. 2014. “Genotypic Correlates of Susceptibility to HIV-1 Attachment Inhibitor BMS-626529, the Active Agent of the Prodrug BMS-663068.” Journal of Antimicrobial Chemotherapy (JAC) 69 (3): 573–81. doi:10.1093/jac/dkt412.